Illumina CMO Phil Febbo departs; separation agreement provides $600K salary continuation

ILLUMINA, INC.

Chief Medical Officer Phil Febbo departed on August 7, 2023.
Separation Agreement signed September 5, 2023: one year base salary ($600,000).
COBRA health insurance premiums paid for 12 months; executive physical benefits for 2023.
Future filing of Separation Agreement as exhibit to upcoming Form 10-Q.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Phil Febbo

Chief Medical Officer

ILMN · ILLUMINA, INC.

Effective: 2023-08-07
Filed: September 8, 2023, 7:59 PM ET

Phil Febbo, Chief Medical Officer, departed the company on August 7, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Phil Febbo departed as Chief Medical Officer at ILLUMINA, INC..

Action: departed
Role: Chief Medical Officer

Exact text from the filing

Phil Febbo, Chief Medical Officer, departed the company on August 7, 2023.

View on SEC.gov

ILLUMINA, INC. filing history →

Source: SEC EDGAR

accession 0001110803-23-000067

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.